79 results
424B2
PLSE
Pulse Biosciences Inc
4 Jun 24
Prospectus for primary offering
4:05pm
, 2024, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. In some cases, you can identify
POS AM
PLSE
Pulse Biosciences Inc
28 May 24
Prospectus update (post-effective amendment)
5:19pm
forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking
8-K
EX-10.3
PLSE
Pulse Biosciences Inc
15 May 24
Pulse Biosciences Enhances Executive Leadership Team
9:05am
to the jurisdiction of the State of California, and agree that such litigation will be conducted in the courts of San Francisco, California
8-K
EX-10.1
PLSE
Pulse Biosciences Inc
15 May 24
Pulse Biosciences Enhances Executive Leadership Team
9:05am
of Sections 8 (severance conditions), 11 (assignment), 12 (notices), 13 (confidential information agreement), 15 (litigation cooperation), and 17 (miscellaneous … by or in active planning by the Company or its subsidiaries or affiliates.
15. Litigation and Regulatory Cooperation. During and after the Executive’s
8-K
d9cwn3nwl2d
27 Nov 23
Regulation FD Disclosure
9:08am
S-8
8zs79v3vmy ov
10 May 23
Registration of securities for employees
4:34pm
8-K
EX-10.1
y9cab9miyniws 0qr5xp
1 May 23
Pulse Biosciences Announces $65 Million Private Placement
4:15pm